In Reply: Transcriptomic Profiling Revealed Lnc-GOLGA6A-1 as a Novel Prognostic Biomarker of Meningioma Recurrence
Language English Country United States Media print-electronic
Document type Journal Article, Comment
PubMed
36700746
DOI
10.1227/neu.0000000000002331
PII: 00006123-202303000-00045
Knihovny.cz E-resources
- MeSH
- Biomarkers MeSH
- Humans MeSH
- Meningeal Neoplasms * genetics MeSH
- Meningioma * genetics MeSH
- Prognosis MeSH
- Transcriptome MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Comment MeSH
- Names of Substances
- Biomarkers MeSH
Department of Neurology University Hospital Olomouc Olomouc Czech Republic
Department of Neurosurgery Svet Zdravia Hospital Michalovce Michalovce Slovak Republic
See more in PubMed
Wang L. Letter: Transcriptomic profiling revealed Lnc-GOLGA6A-1 as a novel prognostic biomarker of meningioma recurrence. Neurosurgery. 2022;91(6):e175.
Slavik H, Balik V, Kokas FZ, et al. Transcriptomic profiling revealed Lnc-GOLGA6A-1 as a novel prognostic biomarker of meningioma recurrence. Neurosurgery. 2022;91(2):360-369.
Rogers L, Barani I, Chamberlain M, et al. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg. 2015;122(1):4-23.
Balik V, Kourilova P, Sulla I, et al. Recurrence of surgically treated parasagittal meningiomas: a meta-analysis of risk factors. Acta Neurochir (Wien). 2020;162(9):2165-2176.
Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957;20(1):22.
Brastianos PK, Galanis E, Butowski N, et al. Advances in multidisciplinary therapy for meningiomas. Neuro-Oncology. 2019;21(supplement_1):i18-i31.
Lemée JM, Corniola MV, Da Broi M, et al. Extent of resection in meningioma: predictive factors and clinical implications. Sci Rep. 2019;9(1):5944.
Slot KM, Verbaan D, Bosscher L, Sanchez E, Vandertop WP, Peerdeman SM. Agreement between extent of meningioma resection based on surgical simpson grade and based on postoperative magnetic resonance imaging findings. World Neurosurg. 2018;111:e856-e862.
Chotai S, Schwartz TH. The Simpson grading: is it still valid? Cancers. 2022;14(8):2007.
Slavik H, Balik V, Vrbkova J, et al. Identification of meningioma patients at high risk of tumor recurrence using microRNA profiling. Neurosurgery. 2020;87(5):1055-1063.
Katz LM, Hielscher T, Liechty B, et al. Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathol. 2018;135(6):955-963.
Nassiri F, Liu J, Patil V, et al. A clinically applicable integrative molecular classification of meningiomas. Nature. 2021;597(7874):119-125.
